Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Ponatinib hydrochloride (AP24534 hydrochloride) | 1114544-31-8 | 99.8% | 569.02 | 100 U
SDP

Catalog No. 5000345437
Encompass_Preferred

Ponatinib hydrochloride is a hydrochloride of ponatinib. Ponatinib is an orally active multi-targeted kinase inhibitor with IC50s of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM, and 5.4 nM for Abl, PDGFRα, VEGFR2, FGFR1, and Src, respectively. It is for research use only and not sold to patients.

  • Orally active multi-targeted kinase inhibitor
  • IC50s: 0.37 nM for Abl, 1.1 nM for PDGFRα, 1.5 nM for VEGFR2, 2.2 nM for FGFR1, and 5.4 nM for Src
  • Reduces viability, migration, and function of human endothelial cells in vitro
  • Protects mice from lethal influenza infection by inhibiting cytokine storm in vivo

Catalog No. 50-003-45437 Supplier Medchemexpress LLC Supplier No. HY10876650MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Ponatinib hydrochloride is a hydrochloride of ponatinib. Ponatinib is an orally active multi-targeted kinase inhibitor with IC50s of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM, and 5.4 nM for Abl, PDGFRα, VEGFR2, FGFR1, and Src, respectively. It is for research use only and not sold to patients.

  • Orally active multi-targeted kinase inhibitor
  • IC50s: 0.37 nM for Abl, 1.1 nM for PDGFRα, 1.5 nM for VEGFR2, 2.2 nM for FGFR1, and 5.4 nM for Src
  • Reduces viability, migration, and function of human endothelial cells in vitro
  • Protects mice from lethal influenza infection by inhibiting cytokine storm in vivo

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.